Serveur d'exploration Tocilizumab - Analysis (France)

Index « Keywords » - entrée « Middle Aged »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Microenvironment < Middle Aged < Molecular Targeted Therapy  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 104.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000210 (2018) Pauline Baudart [France] ; Johann Cesini [France] ; Christian Marcelli [France]Atypical juxta-articular form of Dercum's disease in a patient treated with tocilizumab for rheumatoid arthritis.
000211 (2018) Valérie Devauchelle-Pensec [France] ; Lea Saraux [France] ; Jean Marie Berthelot [France] ; Michel De Bandt [France] ; Divi Cornec [France] ; Dewi Guellec [France] ; Thierry Marhadour [France] ; Sandrine Jousse-Joulin [France] ; Maelenn Gouillou [France] ; Alain Saraux [France]Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable.
000232 (2017) Nihal Martis [France] ; David Chirio [France] ; Viviane Queyrel-Moranne [France] ; Marie-Christine Zenut [France] ; Fanny Rocher [France] ; Jean-Gabriel Fuzibet [France]Tocilizumab-induced hypofibrinogenemia: A report of 7 cases.
000233 (2017) Elina Zuelgaray [France] ; Fanny Domont [France] ; Nathan Peiffer-Smadja [France] ; David Saadoun [France] ; Patrice Cacoub [France]Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease.
000235 (2017) Jean-Jacques Dubost [France] ; Bruno Pereira [France] ; Anne Tournadre [France] ; Zuzana Tatar [France] ; Marion Couderc [France] ; Martin Soubrier [France]The changing face of septic arthritis complicating rheumatoid arthritis in the era of biotherapies. Retrospective single-center study over 35years.
000240 (2017) Ernest Choy [Royaume-Uni] ; Roberto Caporali [Italie] ; Ricardo Xavier [Brésil] ; Bruno Fautrel [France] ; Raim N Sanmarti [Espagne] ; Min Bao [États-Unis] ; Corrado Bernasconi [Suisse] ; Attila Pethö-Schramm [Suisse]Subcutaneous tocilizumab in rheumatoid arthritis: findings from the common-framework phase 4 study programme TOZURA conducted in 22 countries
000244 (2017) Dinesh Khanna [États-Unis] ; Christopher P. Denton [Royaume-Uni] ; Celia J F. Lin [États-Unis] ; Jacob M. Van Laar [Pays-Bas] ; Tracy M. Frech [États-Unis] ; Marina E. Anderson [Royaume-Uni] ; Murray Baron [Canada] ; Lorinda Chung [États-Unis] ; Gerhard Fierlbeck [Allemagne] ; Santhanam Lakshminarayanan [États-Unis] ; Yannick Allanore [France] ; Janet E. Pope [Canada] ; Gabriela Riemekasten [Allemagne] ; Virginia Steen [États-Unis] ; Ulf Müller-Ladner [Allemagne] ; Helen Spotswood [Royaume-Uni] ; Laura Burke [Royaume-Uni] ; Jeffrey Siegel [États-Unis] ; Angelika Jahreis [États-Unis] ; Daniel E. Furst [États-Unis]Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
000245 (2017) Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis ; René Marc Flipo ; Stéphanie Rist ; Bernard Combe [France] ; Jacques Eric Gottenberg [France] ; Thierry Schaeverbeke ; Martin Soubrier ; Olivier Vittecoq ; Maxime Dougados [France] ; Alain Saraux ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France]Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE.
000254 (2017) Michael B. Arnold [Canada] ; Dinesh Khanna [États-Unis] ; Christopher P. Denton [Royaume-Uni] ; Jacob M. Van Laar [Pays-Bas] ; Tracy M. Frech [États-Unis] ; Marina E. Anderson [Royaume-Uni] ; Murray Baron [Canada] ; Lorinda Chung [États-Unis] ; Gerhard Fierlbeck [Allemagne] ; Santhanam Lakshminarayanan [États-Unis] ; Yannick Allanore [France] ; Gabriela Riemekasten [Allemagne] ; Virginia Steen [États-Unis] ; Ulf Müller-Ladner [Allemagne] ; Helen Spotswood [Royaume-Uni] ; Laura Burke [Royaume-Uni] ; Jeffrey Siegel ; Angelika Jahreis ; Daniel E. Furst [États-Unis] ; Janet E. Pope [Canada]Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis
000257 (2017) L. Méry-Bossard [France] ; K. Bagny [France] ; G. Chaby [France] ; A. Khemis [France] ; F. Maccari [France] ; H. Marotte [France] ; J L Perrot [France] ; Z. Reguiai [France] ; M L Sigal [France] ; M. Avenel-Audran [France] ; T. Boyé [France] ; A. Grasland [France] ; J. Gillard [France] ; D. Jullien [France] ; E. Toussirot [France]New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases.
000262 (2017) Nathalie Balandraud [France] ; Gaetan Texier [France] ; Emmanuel Massy [France] ; Olivier Muis-Pistor [France] ; Marielle Martin [France] ; Isabelle Auger [France] ; Marie-Caroline Guzian [France] ; Sandrine Guis [France] ; Thao Pham [France] ; Jean Roudier [France]Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study
000272 (2017) Johanna Sigaux [France] ; Moustafa Hamze [France] ; Claire Daien [France] ; Jacques Morel [France] ; Roman Krzysiek [France] ; Marc Pallardy [France] ; Bernard Maillere [France] ; Xavier Mariette [France] ; Corinne Miceli-Richard [France]Immunogenicity of tocilizumab in patients with rheumatoid arthritis.
000273 (2017) A A Arguinano [France] ; E. Naderi [France] ; N C Ndiaye [France] ; M. Stathopoulou [France] ; S. Dadé [France] ; B. Alizadeh [France] ; S. Visvikis-Siest [France]IL6R haplotype rs4845625*T/rs4537545*C is a risk factor for simultaneously high CRP, LDL and ApoB levels.
000277 (2017) Ghassan Elourimi [France] ; Michael Soussan [France] ; Ursula Warzocha [France] ; Hélène Bugaud [France] ; Robin Dhôte [France] ; Sébastien Abad [France]Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis.
000278 (2017) Amélie Moreau [France] ; Marc Le Vée [France] ; Elodie Jouan [France] ; Claire Denizot [France] ; Yannick Parmentier [France] ; Olivier Fardel [France]Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes.
000282 (2017) Guillermo Carvajal Alegria ; Valérie Devauchelle-Pensec ; Yves Renaudineau [France] ; Alain Saraux ; Jacques-Olivier Pers [France] ; Divi CornecCorrection of abnormal B-cell subset distribution by interleukin-6 receptor blockade in polymyalgia rheumatica.
000286 (2017) Arsene Mekinian [France] ; Guillaume Dervin [France] ; Nathanael Lapidus [France] ; Jean-Emmanuel Kahn [France] ; Louis Terriou [France] ; Eric Liozon [France] ; Eric Grignano [France] ; Jean-Charles Piette [France] ; Odile Beyne Rauzy [France] ; Vincent Grobost [France] ; Pascal Godmer [France] ; Jerome Gillard [France] ; Julien Rossignol [France] ; David Launay [France] ; Achille Aouba [France] ; Thierry Cardon [France] ; Laurence Bouillet [France] ; Jonathan Broner [France] ; Julien Vinit [France] ; Lionel Ades [France] ; Fabrice Carrat [France] ; Clementine Salvado [France] ; Eric Toussirot [France] ; Mathilde Versini [France] ; Nathalie Costedoat-Chalumeau [France] ; Jean Baptiste Fraison [France] ; Philippe Guilpain [France] ; Pierre Fenaux [France] ; Olivier Fain [France]Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients.
000288 (2017) J. Choi [États-Unis] ; O. Aubert [France] ; A. Vo [États-Unis] ; A. Loupy [France] ; M. Haas [États-Unis] ; D. Puliyanda [États-Unis] ; I. Kim [États-Unis] ; S. Louie [États-Unis] ; A. Kang [États-Unis] ; A. Peng [États-Unis] ; J. Kahwaji [États-Unis] ; N. Reinsmoen [États-Unis] ; M. Toyoda [États-Unis] ; S C Jordan [États-Unis]Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients.
000289 (2017) Marie Desplats [France] ; Tristan Pascart [France] ; Germain Jelin [France] ; Laurène Norberciak [France] ; Peggy Philippe [France] ; Eric Houvenagel [France] ; Vincent Goeb [France] ; René-Marc Flipo [France]Are abatacept and tocilizumab intravenous users willing to switch for the subcutaneous route of administration? A questionnaire-based study.
000292 (2017) Marie Hugo [France] ; Audrey Pierreisnard [France] ; Nadia Mehsen-Cetre [France] ; Henri Gin [France] ; Thierry Schaeverbeke [France] ; Vincent Rigalleau [France]Action of tocilizumab on energy expenditure in rheumatoid arthritis: A prospective study using calorimetry and actimetry.
000298 (2016) A. Deroux [France] ; F. Andry [France] ; L. Bouillet [France][Macrophage activation syndrome secondary to tocilizumab: Myth or reality?].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i -k "Middle Aged" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i  \
                -Sk "Middle Aged" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Middle Aged
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021